Teracyte Analytics
Digitizing Biological Processes
Startup Seed Health Tech & Life Sciences Est. 2020
Total Raised
$1.5M
Seed
Last Round
$1.5M
1 rounds
Investors
1
1 public
Team
2
11-50 employees
Confidence
81/100
About
TeraCyte developed a platform for high throughput temporal analysis of live single-cells, based on proprietary array chips, an imaging system and analytical tools. The platform allows for capturing and retaining suspension cells in dedicated cell arrays and real-time monitoring of cell function with high sensitivity fluorescent imaging and a matching high resolution brightfield image. TeraCyte’s AI models can distinguish between various cell types, count cells and identify cell-cell interactions. TeraCyte’s solution can be used for discovery, development and manufacturing of cell therapies, biological and small molecule drugs. TeraCyte is currently set to begin collaborations with cell therapy companies on the development of high value applications.
Classification
Sector
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Core Technology
Simulation & ImagingSemiconductors & ElectronicsChipsetsArtificial Intelligence
Target Customer
Healthcare & Life SciencesLife SciencesBiotechnologyPharmaceuticals
Business Model
B2B
Tags
drug-developmentpredictive-analyticspharmaceuticalscellsbiotechnologycell-therapy
Funding & Events
Jan 2022
Seed $1.5M
Israel Innovation Authority
Details
Product Stage
Beta
Employees
11-50
Exact Count
19
Founded
2020
Registrar
516174778
Locations
Ha-Tokhen St 17, Caesarea, 3079892, Israel
Links
Website
LinkedIn
Facebook
Admin
Last Update
Mar 19, 2025
Verified by
Yanina Wainscheinker
Missing
sector, news, markets, not claimed
Team (2)
Yoav Nissan-cohen
Co-founder & CEO
Founder
Gal Lenz
Co-founder & CTO
Founder
Internal
Created by
Yanina Wainscheinker (yanina.wainscheinker@sncentral.org)
Created
2024-01-23T00:00:00.000Z